Loading stock data...

Thyrocare Technologies Limited

NSE: THYROCARE BSE: THYROCARE

NSE
731.00 22.40 (3.16%)

Prev Close

708.6

Open Price

708.6

Volume

37,171

Today Low / High

708.15 / 735.95

52 WK Low / High

571.4 / 1055

Range

694 - 768

BSE
730.80 21.80 (3.07%)

Prev Close

709

Open Price

692.35

Volume

5,774

Today Low / High

692.35 / 736.75

52 WK Low / High

570.75 / 1053.05

Range

694 - 767

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 731 (target range: 694 - 768), reflecting a change of 22.4 (3.16116%). On the BSE, it is listed at 730.8 (target range: 694 - 767), showing a change of 21.8 (3.07475%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.

21 Apr 708.60 3.16%
17 Apr 705.05 0.50%
16 Apr 717.20 -1.53%
15 Apr 702.60 1.54%
11 Apr 709.15 -1.06%
09 Apr 685.65 2.90%
08 Apr 690.05 -0.64%
07 Apr 670.00 1.88%
04 Apr 724.00 -4.36%
03 Apr 714.20 0.92%
02 Apr 725.00 -0.59%
01 Apr 682.70 5.71%
28 Mar 698.00 -2.63%
27 Mar 715.00 -2.01%
26 Mar 731.00 -1.89%
25 Mar 740.85 -1.43%
24 Mar 740.60 -0.74%

Thyrocare Technologies Limited Graph

Thyrocare Technologies Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Thyrocare Technologies Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 731.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 730.80 738.11 664.30 - 811.92
745.42 596.33 - 894.50
752.72 526.91 - 978.54
Bearish Scenario 730.80 723.49 651.14 - 795.84
716.18 572.95 - 859.42
708.88 496.21 - 921.54

Overview of Thyrocare Technologies Limited

ISIN

INE594H01019

Industry

Medical - Diagnostics & Research

Vol.Avg

45,795

Market Cap

38,738,211,950

Last Dividend

18

Official Website

Visit Website

IPO Date

2016-05-10

DCF Diff

-891.28

DCF

1,625

Financial Ratios Every Investor Needs

Stock Dividend of THYROCARE

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2024-08-16 August 16, 24 18 18 2024-08-16 2024-09-22
2023-04-20 April 20, 23 18 18 2023-04-20 2023-04-29
2022-05-11 May 11, 22 15 15 2022-05-12 2022-05-29
2021-06-17 June 17, 21 15 15 2021-06-18 2021-07-26
2020-11-12 November 12, 20 10 10 2020-11-13 2020-11-27

Stock Rating Details for THYROCARE

Metric Value Recommendation
Overall Rating C Sell
DCF Score 5 Strong Buy
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2024-03-31 571.88 Cr 321.57 Cr 250.31 Cr 0.4377 0.00 Cr 143.15 Cr 92.71 Cr 70.76 Cr 13.42 148.13 Cr 0.1237
2023-03-31 526.67 Cr 163.23 Cr 363.44 Cr 0.6901 0.00 Cr 23.35 Cr 81.39 Cr 64.49 Cr 12.16 130.95 Cr 0.1224
2022-03-31 588.86 Cr 169.69 Cr 419.17 Cr 0.7118 0.00 Cr 17.38 Cr 201.02 Cr 176.14 Cr 33.30 264.14 Cr 0.2991
2021-03-31 494.62 Cr 163.90 Cr 330.72 Cr 0.6686 0.00 Cr 13.35 Cr 141.12 Cr 113.15 Cr 21.41 183.69 Cr 0.2288
2020-03-31 433.20 Cr 117.09 Cr 316.11 Cr 0.7297 0.00 Cr 15.35 Cr 141.66 Cr 88.40 Cr 16.74 173.66 Cr 0.2041

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2024-03-31 9.30 Cr 643.88 Cr 116.25 Cr 526.7700 Cr 42.34 Cr 33.04 Cr 47.52 Cr 203.70 Cr 6.16 Cr 0.00 Cr 25.83 Cr 90.4800 Cr
2023-03-31 17.77 Cr 632.72 Cr 97.50 Cr 534.3000 Cr 23.31 Cr 5.54 Cr 27.67 Cr 194.43 Cr 36.65 Cr 0.00 Cr 22.10 Cr 77.1000 Cr
2022-03-31 13.63 Cr 607.66 Cr 81.09 Cr 526.5700 Cr 20.70 Cr 7.07 Cr 24.53 Cr 186.79 Cr 31.82 Cr 0.00 Cr 20.92 Cr 64.5200 Cr
2021-03-31 13.20 Cr 545.80 Cr 118.52 Cr 427.2800 Cr 8.49 Cr -4.71 Cr 23.36 Cr 160.07 Cr 39.85 Cr 9.19 Cr 21.10 Cr 95.1000 Cr
2020-03-31 8.70 Cr 469.33 Cr 102.67 Cr 366.6600 Cr 12.44 Cr 3.74 Cr 20.62 Cr 172.58 Cr -4.25 Cr 3.53 Cr 21.17 Cr 81.6900 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2024-03-31 167.6300 Cr -91.2800 Cr -84.8100 Cr 106.0500 Cr -8.4700 Cr 9.3000 Cr -61.5800 Cr 70.7600 Cr 21.5900 Cr -95.2700 Cr -19.8500 Cr
2023-03-31 129.3100 Cr -38.9900 Cr -86.1800 Cr 85.6600 Cr 4.1400 Cr 17.7700 Cr -43.6500 Cr 87.4100 Cr 0.0000 Cr -79.3500 Cr -3.1400 Cr
2022-03-31 113.4100 Cr -23.5700 Cr -89.4100 Cr 75.5800 Cr 0.4300 Cr 13.6300 Cr -37.8300 Cr 227.9000 Cr 0.0000 Cr -79.3100 Cr -1.1700 Cr
2021-03-31 116.0300 Cr -50.2300 Cr -61.5700 Cr 87.7700 Cr 4.2400 Cr 13.2000 Cr -28.2600 Cr 152.5400 Cr -2.5000 Cr -52.8400 Cr -2.7400 Cr
2020-03-31 167.6300 Cr 0.9500 Cr -164.7800 Cr 157.7300 Cr 3.8000 Cr 8.7100 Cr -9.9000 Cr 146.4900 Cr 0.0000 Cr -159.0000 Cr -2.5400 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2024-12-31 165.92 Cr 45.16 Cr 120.76 Cr 0.7278 24.67 Cr 19.11 Cr 3.58 45.58 Cr 0.1152
2024-09-30 177.36 Cr 93.55 Cr 83.81 Cr 0.4725 35.22 Cr 26.67 Cr 4.99 50.61 Cr 0.1504
2024-06-30 156.91 Cr 85.54 Cr 71.37 Cr 0.4548 31.28 Cr 24.17 Cr 4.56 46.26 Cr 0.1540
2024-03-31 154.25 Cr 86.20 Cr 68.05 Cr 0.4412 20.75 Cr 17.78 Cr 3.54 37.30 Cr 0.1153
2023-12-31 134.74 Cr 38.42 Cr 96.32 Cr 0.7149 20.98 Cr 15.35 Cr 2.90 34.32 Cr 0.1139

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2024-09-30 45.73 Cr 94.33 Cr 137.56 Cr 47.93 Cr 44.07 Cr 244.84 Cr 187.26 Cr 597.08 Cr 108.41 Cr
2024-06-30 -179.96 Cr 359.92 Cr 179.96 Cr 0.00 Cr 0.00 Cr 179.96 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 39.89 Cr 136.75 Cr 176.64 Cr -30.53 Cr 47.52 Cr 278.51 Cr 203.71 Cr 643.88 Cr 116.25 Cr
2023-12-31 -99.34 Cr 198.68 Cr 99.34 Cr 0.00 Cr 0.00 Cr 99.34 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-09-30 14.67 Cr 90.81 Cr 105.48 Cr 55.36 Cr 32.28 Cr 209.06 Cr 193.48 Cr 592.69 Cr 105.05 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-06-30 24.17 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 17.78 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 15.35 Cr 26.94 Cr 0.00 Cr 0.00 Cr 26.94 Cr 41.61 Cr 14.67 Cr 0.00 Cr 26.94 Cr
2023-09-30 20.34 Cr 21.30 Cr 0.00 Cr 0.00 Cr 21.30 Cr 14.67 Cr -6.63 Cr 0.00 Cr 21.30 Cr
2023-06-30 17.30 Cr 19.66 Cr 0.00 Cr 0.00 Cr 19.66 Cr 37.43 Cr 17.77 Cr 0.00 Cr 19.66 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Diagnostics & Research

Company Name Symbol Price Market Cap Volume
Dr. Lal PathLabs Limited LALPATHLAB ₹2,727.20 ₹227,249,424,399.00 ₹65,169.00
Vijaya Diagnostic Centre Limited VIJAYA ₹1,100.20 ₹112,920,435,256.00 ₹1,846,084.00
Metropolis Healthcare Limited METROPOLIS ₹1,700.90 ₹87,224,063,812.00 ₹80,914.00
Thyrocare Technologies Limited THYROCARE ₹731.00 ₹38,738,211,950.00 ₹37,171.00
Krsnaa Diagnostics Limited KRSNAA ₹809.25 ₹26,130,490,708.00 ₹73,440.00

Key Executives

Head of Strategy & Investor Relations
Mr. Pratik Hire

Gender: male

Year Born:

Vice President
Mr. Aditya Shinde

Gender: male

Year Born: 1989

Strategy Manager
Mr. Kapil Gupta

Gender: male

Year Born:

Vice President of Lab Operations & Quality
Ms. Preet Kaur

Gender: female

Year Born: 1983

Company Secretary & Compliance Officer
Mr. Brijesh Kumar

Gender: male

Year Born:

Chief Financial Officer
Mr. Alok Kumar Jagnani

Gender: male

Year Born:

Chief Operating Officer
Mr. K. KallathiKumar

Gender: male

Year Born:

Chief Commercial Officer
Mr. Nitin Chugh

Gender: male

Year Born:

MD, Chief Executive Officer & Chairman
Mr. Rahul Franklin Guha

Gender: male

Year Born: 1978

FAQs about Thyrocare Technologies Limited

Who is the CEO of the company?

The CEO is Mr. Rahul Franklin Guha.

What is the current market price of the stock?

The current price is ₹731.00.

What is the 52-week price range?

The range is ₹571.4-1055.

What is the market capitalization of the company?

The market capitalization is ₹3,873.82 crores.

What is the dividend yield?

The dividend yield is 2.46%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 44.48.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Thyrocare Technologies Limited (ISIN: INE594H01019) is a leading Medical - Diagnostics & Research in India. With a market capitalization of ₹3,873.82 crores and an average daily volume of 45,795 shares, it operates in the Medical - Diagnostics & Research. The company last declared a dividend of ₹18.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack